Home › Funds › EDGAR LOMAX CO/VA › GILD

EDGAR LOMAX CO/VA position in GILD

GILEAD SCIENCES INC · Health Care

EDGAR LOMAX CO/VA reported holding 146,040 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$21.8M, representing 1.65% of its reported portfolio and ranking #21 among its reported holdings. EDGAR LOMAX CO/VA has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)146.04K sh
Reported value held$21.77M
Portfolio Weight1.65%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EDGAR LOMAX CO/VA's GILD position evolved

EDGAR LOMAX CO/VA first disclosed a stake in GILD in Q3 2023 at 103,924 shares (US$7.8M). The position peaked in Q1 2025 at 231,390 shares, worth US$25.9M. Across 13 filings, EDGAR LOMAX CO/VA increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 146,040 shares valued at US$21.8M — a reduction of -1,600 shares quarter over quarter.. Notable position changes include a 32% increase in Q1 2024 (shares fell 6% over the following quarter), a 84% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 103.92K $7.79M New
Q4 2023 99.90K $8.09M Reduce
Q1 2024 132.31K $9.69M Add
Q2 2024 129.98K $8.92M Reduce
Q3 2024 127.99K $10.73M Reduce
Q4 2024 125.59K $11.60M Reduce
Q1 2025 231.39K $25.93M Add
Q2 2025 227.66K $25.24M Reduce
Q3 2025 175.30K $19.46M Reduce
Q4 2025 171.33K $21.03M Reduce
Q1 2026 156.71K $21.84M Reduce
Q2 2026 147.64K $18.65M Reduce
Q3 2026 146.04K $21.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has EDGAR LOMAX CO/VA held GILD?

EDGAR LOMAX CO/VA has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EDGAR LOMAX CO/VA's current position in GILD?

As of Q3 2026, EDGAR LOMAX CO/VA holds 146.04K shares of GILD (GILEAD SCIENCES INC), valued at $21.77M, representing 1.65% of its reported portfolio and ranking #21.

Has EDGAR LOMAX CO/VA been buying or selling GILD?

In the latest 13F filing (Q3 2026), EDGAR LOMAX CO/VA reduced its position in GILD. The position peaked in Q1 2025 at 231.39K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.